Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

Sato, Kei (57216496603); White, Nicole (55441104800); Fanning, Jonathon P. (53983925400); Obonyo, Nchafatso (20735366100); Yamashita, Michael H. (36629635200); Appadurai, Vinesh (55634491600); Ciullo, Anna (56278087300); May, Meryta (21834310200); Worku,
Sato K.; White N.; Fanning J.P.; Obonyo N.; Yamashita M.H.; Appadurai V.; Ciullo A.; May M.; Worku E.T.; Helms L.; Ohshimo S.; Juzar D.A.; Suen J.Y.; Bassi G.L.; Fraser J.F.; Arora R.C.; Dalton H.J.; Laffey J.; Brodie D.; Fan E.; Torres A.; Chiumello D.;
Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study
BMC Cardiovascular Disorders
Background: The influence of renin–angiotensin–aldosterone system (RAAS) inhibitors on the critically ill COVID-19 patients with pre-existing hypertension remains uncertain. This study examined the impact of previous use of angiotensin-converting enzyme i
Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Critical care; Severe acute respiratory syndrome coronavirus 2
Funding text 1: This study received discretionary funding from University of Queensland, Wesley Medical Research, The Prince Charles Hospital Foundation, The Health Research Board of Ireland, Biomedicine international training research programme for excel
K. Sato; Critical Care Research Group, The Prince Charles Hospital, Brisbane, Level 3, Clinical Sciences Building, Chermside, 4032, Australia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.
BioMed Central Ltd
14712261
35321649
BMC Cardiovasc. Disord.
Sato K., Critical Care Research Group, The Prince Charles Hospital, Level 3, Clinical Sciences Building, Chermside, Brisbane, 4032, QLD, Australia, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; White N., Australian Centre for He
Critical Care Research Group, The Prince Charles Hospital, Level 3, Clinical Sciences Building, Chermside, Brisbane, 4032, QLD, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Australian Centre for Health Services Innov
57216496603; 55441104800; 53983925400; 20735366100; 36629635200; 55634491600; 56278087300; 21834310200; 57218324688; 57544863600; 15731705200; 55358712500; 35081233700; 13611676700; 34769608400; 7202894376; 7103262112; 26643063000; 8333064800; 7006443489;
3
2022
Article